Synthego Corporation

📍 Menlo Park, United States🗓 Founded 2012👥 293 employees💰 Last funded Jan 2019
Synthego is a genome engineering company enabling the acceleration of life science research and development in the pursuit of improved human health. The company leverages machine learning, automation, and gene editing to build platforms for science at scale. By vertically integrating hardware, software, bioinformatics, chemistry, and molecular biology, Synthego is at the forefront of innovation advancing the next generation of medicines through providing access to genome editing at an unprecedented scale. //// Our Culture of Diversity: Different Faces from Different Places At Synthego, our differences make us unique, help us innovate, and allow us to persevere. We stand firmly behind our values, strive to achieve representation, and celebrate diversity in perspectives and backgrounds. We welcome all team members to be their best selves as we move forward towards fulfilling our shared vision of revolutionizing genome engineering technology to help make biological therapies accessible to all patients.
3
Total investors
1
Early stage
1
Mid stage
1
Late stage
2012
Founded
Investor geography2 countries
United States
1
Australia
1
Investor activity2013–2019 · investors recorded per year
201312016120191
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Synthego Corporation?
Synthego Corporation has 3 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage and 1 late-stage investors.
When did Synthego Corporation last raise funding?
The most recent investment in Synthego Corporation recorded on gritt.io was in January 2019.
When was Synthego Corporation founded?
Synthego Corporation was founded in 2012.
What industry is Synthego Corporation in?
Synthego Corporation operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Synthego Corporation based?
Synthego Corporation is headquartered in Menlo Park, United States.